Cite
Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas aeruginosa Isolates Expressing Combinations of Most Relevant beta-Lactam Resistance Mechanisms
MLA
Torrens, G., et al. Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas Aeruginosa Isolates Expressing Combinations of Most Relevant Beta-Lactam Resistance Mechanisms. Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....451144e1bf3cc35f7b68a65b74e76e55&authtype=sso&custid=ns315887.
APA
Torrens, G., Cabot, G., Ocampo-Sosa, A., Conejo, M., Zamorano, L., Navarro, F., Pascual, A., Martinez-Martinez, L., & Oliver, A. (2016). Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas aeruginosa Isolates Expressing Combinations of Most Relevant beta-Lactam Resistance Mechanisms.
Chicago
Torrens, G, G Cabot, Aa Ocampo-Sosa, Mc Conejo, L Zamorano, F Navarro, A Pascual, L Martinez-Martinez, and A Oliver. 2016. “Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas Aeruginosa Isolates Expressing Combinations of Most Relevant Beta-Lactam Resistance Mechanisms,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....451144e1bf3cc35f7b68a65b74e76e55&authtype=sso&custid=ns315887.